Oxis 9mcg Turbuhaler Clinical Experience Investigation

A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects

NCT01754844 ·Status: COMPLETED ·Phase: PHASE1

Comparison Between Symbicort® and Prednisolone in COPD

NCT00259779 ·Status: COMPLETED ·Phase: PHASE3

The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01205269 ·Status: COMPLETED ·Phase: PHASE2

Lung Bioavailability and Total Systemic Exposure to Beclomethasone17MonoPropionate and Formoterol Across Two Strengths of NEXThaler Inhalation Powder

NCT01738087 ·Status: COMPLETED ·Phase: PHASE2

First Time in Human Study With GSK1325756

NCT01209052 ·Status: COMPLETED ·Phase: PHASE1

Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01713075 ·Status: COMPLETED

Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation

NCT01332097 ·Status: COMPLETED ·Phase: PHASE2

This Study in Healthy Men Tests How Different Doses of BI 1265162 Are Taken up in the Body and How Well They Are Tolerated.

NCT03576144 ·Status: COMPLETED ·Phase: PHASE1

Investigate the Safety, Tolerability and Pharmacokinetics of CHF6523 in Healthy and in COPD Subjects

NCT04032535 ·Status: COMPLETED ·Phase: PHASE1

To Assess the Safety, Tolerability, and Pharmacokinetics of AZD7624 in Healthy Volunteers and COPD Patients

NCT01817855 ·Status: COMPLETED ·Phase: PHASE1

Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.

NCT00430300 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of Two Fixed Dose Combinations of Aclidinium Bromide With Formoterol Fumarate

NCT01078623 ·Status: COMPLETED ·Phase: PHASE2

Safety, Toleration and Efficacy of Single Inhaled Doses of PF-00610355 in Chronic Obstructive Pulmonary (COPD) Patients.

NCT00783406 ·Status: COMPLETED ·Phase: PHASE2

Budesonide / Formoterol in Treatment of Exacerbations of COPD

NCT00239278 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo

NCT01049360 ·Status: COMPLETED ·Phase: PHASE2

Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705

NCT00500461 ·Status: COMPLETED ·Phase: PHASE1

A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD

NCT00280371 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU

NCT00628862 ·Status: COMPLETED ·Phase: PHASE3

Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPD

NCT00634413 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Twice Daily 60mg AZD9668 in COPD for 12 Weeks in Patients on Background Budesonide/Formoterol

NCT01023516 ·Status: COMPLETED ·Phase: PHASE2

A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT01233232 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT01266135 ·Status: TERMINATED ·Phase: PHASE2

Efficacy Study of the Effect of Budesonide on Emphysema

NCT00232674 ·Status: COMPLETED ·Phase: PHASE4

Multiple Dose Healthy Volunteer Safety Pharmacokinetics Study

NCT00864786 ·Status: COMPLETED ·Phase: PHASE1

A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD

NCT01636713 ·Status: COMPLETED ·Phase: PHASE3